Baylinson Ilene R.'s Form 4 filing
Maximus, Inc. (MMS) · filed Feb 14, 2023
- Accession no.
- 0001032220-23-000007
- Filed
- Feb 14, 2023
- Trade date
- Feb 10, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $790.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baylinson Ilene R.CIK 0001791080 | Officer (General Mgr - Health & Human) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | Common Stock | SSaleDisposed | −9,550 | $82.74F1 | −$790,167 | 10,044 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The weighted average sales price for prices ranging from $82.69 to $82.88. The reporting person will provide full information regarding the number of shares purchased or sold at each separate price upon request by the Commission staff, the issuer, or a security holder of the issuer.
Referenced by the price of 1 transaction in Table I.